Showing results (111-120 of 216) with videos related to
Sort By:
Pageof 22
Orphanet Journal of Rare Diseases|July 2, 2025
Criteria to evaluate unmet health-related needs of persons living with rare diseases and their caregivers: rapid literature review and stakeholder consultationsZilke Claessens, Alice Vanneste, Charlotte Van Isterdael, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 21, 2017
Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and RheumatologistsEline van Overbeeke, Birgit De Beleyr, Jan de Hoon, et al.Journal of Pharmaceutical Policy and Practice|June 23, 2021
Knowledge and perception of biosimilars in ambulatory care: a survey among Belgian community pharmacists and physiciansLiese Barbier, Yannick Vandenplas, Steven Simoens, et al.Journal of Market Access & Health Policy|April 24, 2026
When Do Annuity-Based Payments Help to Address the Affordability Challenge of Funding Advanced Therapies? Insights from a Budget Impact SimulationWalter Van Dyck, Sissel Michelsen, David Veredas, et al.Frontiers in Medicine|July 23, 2021
Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative StudyRosanne Janssens, Tamika Lang, Ana Vallejo, et al.Frontiers in Medical Technology|March 2, 2026
Early and accelerated access programs for medical devices in the European Union: mapping regulatory derogations and national schemesBaptiste Haon, Mira Hartmann, Sanae Akodad, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 9, 2015
Chemotherapy drug shortages in paediatric oncology: A 14-year single-centre experience in BelgiumTiene Bauters, Barbara Om Claus, Koen Norga, et al.Frontiers in Pharmacology|June 24, 2017
The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial LandscapeEvelien Moorkens, Nicolas Meuwissen, Isabelle Huys, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 21, 2025
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative StudyElif Car, Liese Barbier, Ingrid Schwarzenberger, et al.British Journal of Cancer|July 2, 2019
The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilarsLiese Barbier, Paul Declerck, Steven Simoens, et al.Pageof 22